Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases
Status:
Recruiting
Trial end date:
2024-04-13
Target enrollment:
Participant gender:
Summary
Dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) is a potentially powerful
diagnostic tool for the management of brain cancer and other conditions in which the
blood-brain barrier is compromised. This trial studies how well precise DCE MRI works in
diagnosing participants with high grade glioma that has come back or melanoma that has spread
to the brain. The specially-tailored acquisition and reconstruction (STAR) DCE MRI could
provide improved assessment of brain tumor status and response to therapy.